Search

  • HOME
  • Search
Original Articles
11568
Clinical Characteristics of Allergy to a Brinzolamide 1.0%/Brimonidine 0.2% Fixed Combination in Korean Glaucoma Patients
In Ki Park, Seon Ha Bae, Kyoung Woo Kim, Yeoun Sook Chun
J Korean Ophthalmol Soc. 2020;61(9):1065-1071.   Published online September 15, 2020
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Comparison of the Toxicity of Olopatadine Anti-allergic Ophthalmic Agents on Rabbit Conjunctival Cells.
Young Hwan Jeong, Su Gyeong Jang, Jong Soo Lee
J Korean Ophthalmol Soc. 2019;60(12):1176-1184.   Published online December 15, 2019
PDFPDF    
Comparison of Allergy Prevalence between Brimonidine/Timolol Fixed Combination and 0.15% Brimonidine in Glaucoma Patients.
Eun Jung Park, Yeoun Sook Chun
J Korean Ophthalmol Soc. 2018;59(5):451-458.   Published online May 15, 2018
PDFPDF    
Case Reports
Ocular Side Effects Induced by 0.25% Alcaftadine Ophthalmic Solution.
Jong Soo Lee, Jong Moon Park, Hyun Kyung Cho, Su Jin Kim, Hyoun Do Huh, Young Min Park
J Korean Ophthalmol Soc. 2017;58(5):595-599.   Published online May 15, 2017
PDFPDF    
Occlusive Retinal Vasculitis Associated with Intravenous Ceftriaxone Injection.
Ju Yong Seok, Seung Jae Lee, Min Jin Oh, Soo Young Lee
J Korean Ophthalmol Soc. 2013;54(3):508-512.   Published online March 15, 2013
PDFPDF    
Original Articles
The Expression of Adhesion Molecules in Experimental Allergic and Chemical Conjunctivitis.
Hee Bae Ahn, Sae Heun Rho, Young Hyun Yoo
J Korean Ophthalmol Soc. 1998;39(10):2254-2264.   Published online October 1, 1998
PDFPDF    

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374



ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next